Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/22221751.2020.1761267 http://scihub22266oqcxt.onion/10.1080/22221751.2020.1761267 32380903!7241448!32380903     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Emerg+Microbes+Infect 2020 ; 9 (1): 900-902 Nephropedia Template TP {{tp|p=32380903|t=2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 |pdf=|usr=}}{{32380903}} gab.com Text Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 JO: Emerg Microbes Infect http://www.kidney.de/pget.php?&tw=1&pmid=32380903 #FOAvip Despite initial findings indicating that SARS-CoV and SARS-CoV-2 are genetically related belonging to the same virus species and that the two viruses used the same entry receptor, angiotensin-converting enzyme 2 (ACE2), our data demonstrated that there is no detectable cross-neutralization by SARS patient sera against SARS-CoV-2. We also found that there are significant levels of neutralizing antibodies in recovered SARS patients 9-17 years after initial infection. These findings will be of significant use in guiding the development of serologic tests, formulating convalescent plasma therapy strategies, and assessing the longevity of protective immunity for SARS-related coronaviruses in general as well as vaccine efficacy. Twit Text FOAVip Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 ????Emerg Microbes Infect http://www.kidney.de/pget.php?&tw=1&pmid=32380903 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32380903 #FOAvip English Wikipedia <ref>{{Cite pmid|32380903}}</ref> Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 #MMPMID32380903 Anderson DE; Tan CW; Chia WN; Young BE; Linster M; Low JH; Tan YJ; Chen MI; Smith GJD; Leo YS; Lye DC; Wang LF Emerg Microbes Infect 2020[Dec]; 9 (1): 900-902 PMID32380903show ga Despite initial findings indicating that SARS-CoV and SARS-CoV-2 are genetically related belonging to the same virus species and that the two viruses used the same entry receptor, angiotensin-converting enzyme 2 (ACE2), our data demonstrated that there is no detectable cross-neutralization by SARS patient sera against SARS-CoV-2. We also found that there are significant levels of neutralizing antibodies in recovered SARS patients 9-17 years after initial infection. These findings will be of significant use in guiding the development of serologic tests, formulating convalescent plasma therapy strategies, and assessing the longevity of protective immunity for SARS-related coronaviruses in general as well as vaccine efficacy. |Antibodies, Viral/*blood[MESH] |Betacoronavirus/immunology[MESH] |Broadly Neutralizing Antibodies/immunology[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |Coronavirus Infections/*immunology/therapy[MESH] |Humans[MESH] |Immunization, Passive/standards[MESH] |Pandemics[MESH] |Pneumonia, Viral/*immunology[MESH] |SARS-CoV-2[MESH] |Severe Acute Respiratory Syndrome/*immunology[MESH] |Severe acute respiratory syndrome-related coronavirus/*immunology[MESH] |Time Factors[MESH]Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing